Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors

New capabilities and simple, standard site experience cut trial time and expense
Fixed price implementation to get up and running quickly
Industry advances to connected trials as 
seven of the top 20 biopharmas adopt Veeva Site Connect

SYDNEY, Sept. 9, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced, in a major step forward for clinical trial execution, the newest release of Veeva Site Connect, adding powerful new capabilities and a streamlined site-centric experience to simplify and standardize sponsor-site collaboration. With Veeva Site Connect, sponsors reduce the time and effort of site start-up, study conduct, and closeout for higher-quality trials at a significantly lower cost.

"By standardizing how information is shared across all sites in one application with Veeva Site Connect, we aim to save time and effort that can be focused on treating patients," said a clinical operations excellence leader at a top 20 biopharma. "Our goal is to eliminate manual handoffs and inefficiencies for faster site start-up, more efficient monitoring, and simplified study closeout."

To deliver better trial execution in less time, the expansion of Veeva Site Connect includes major application and implementation advances.

"I would be ecstatic if all our sponsors use Veeva Site Connect. It gives sites a much more efficient way to collaborate with sponsors, maintain regulatory compliance, and get critical therapies to patients faster," said Alisha Garibaldi, CEO, Skylight Health Research. "The less time we spend doing administrative work in systems, the more time we have to execute trials and help patients."

"By implementing Veeva Site Connect for our safety letter distribution process, we anticipate achieving a significant reduction in manual processing while enhancing oversight and compliance," said Marta Jureczko-Hinzmann, head of global clinical solution services at AstraZeneca. "Sharing safety letters across all sites globally within a single application will allow us to harmonize the entire process across the company and optimize how we allocate valuable resources."

Veeva Site Connect is part of Veeva Clinical Platform, the complete and connected solution supporting patients, sites, and sponsors. Veeva Site Connect plays a critical role as the industry moves to simplify and standardize site collaboration, and seven of the top 20 biopharmas have already adopted Veeva Site Connect to streamline trials.

Additional Information

For more on Veeva Site Connect, visit: veeva.com/VeevaSiteConnect 
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

About Veeva Systems

Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2024 and in our subsequent SEC filings, which you can access at sec.gov.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors

PARIS, Sept. 16, 2024 /PRNewswire/ -- Mugler announces the release of a documentary directed by Matthieu Menu and produced by Terminal 9 that takes the audience behind-the-scenes of key moments in the lead up to the French house's 50^th anniversary including the making of the Spring/Summer 2024 runway show by Casey Cadwallader.

Since its first apparition on Earth in 1974, Mugler has become synonymous with fashion and fragrance that is fierce, fascinating, and fantastical. Rooted deeply in the entertainment industry and beloved by boundary-pushing performers such as Beyoncé, Lady Gaga, and Dua Lipa for decades, Mugler is more than a house - it's a movement, a true cultural force shaping pop culture with its unwavering commitment to empowerment and inclusivity. Mugler has long embodied the spirit of bold self-expression, continually redefining the art of trailblazing in the world of high fashion and avant-garde fragrance.

This autumn, the French fashion house prepares to enthrall with Inside the Dream: Mugler, an exclusive documentary directed by Matthieu Menu and produced by Terminal 9. 60-minutes that dive deep into the conception and realization of key Mugler events in the lead up to the house's 50th anniversary.

The cinematic journey offers an unparalleled glimpse into the creative synapses and constellations with the Mugler universe, offering an intimate audience with Fashion Creative Director Casey Cadwallader, blending unseen archive footage with runway backstage and behind-the-scenes of the iconic Angel and Alien fragrance campaigns starring Hunter Schafer and Anok Yai, respectively.

The narrative is a celebration of a visionary heritage, exploring half a century of firsts - from Manfred Thierry Mugler's revolutionary impact on fashion and discovering the gourmand olfactive family with the Angel fragrance to Casey Cadwallader's spectacular fashion presentations and cutting-edge innovations. The documentary reveals the making of Zendaya's show-stopping appearance in the chrome robot Maschinenmensch from the Fall/Winter 1995-1996 'Cirque d'hiver' collection for the premier of Dune 2, capturing the electrifying essence of Mugler's impact on the world's red carpets.

"50 years of Mugler is a testament to the power of bold creativity. With Fashion Creative Director Casey Cadwallader, the brand continues to honor Manfred Thierry Mugler's transformative legacy and shape the future of fashion and fragrance together, with its iconic designs and groundbreaking innovations." Danièle Lahana-Aidenbaum, Global Brand President Mugler Fashion & Fragrances.

Featuring iconic fashion figures associated with the house of Mugler such as Pat Cleveland, Iman Bowie, Zendaya, Paris Hilton, Law Roach, as well as key insiders such as Casey Cadwallader – Fashion Creative Director, Cyril Chapuy - L'Oréal Luxe President , Danièle Lahana-Aidenbaum - Global Brand President Mugler Fashion & Fragrances, Olivier Cresp - Master Perfumer DSM-FIRMENICH, just to name a few, and a colorful cast of creatives, the documentary captures the essence of empowerment and fierce spirit that has long defined the brand.

Inside the Dream: Mugler will be available to watch exclusively on Canal+ in France from September 25^th and soon worldwide on selected platforms including Prime Video.

Oanna Lepron - Oanna.LEPRON@loreal.com

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

INSIDE THE DREAM: MUGLER, THE NEW DOCUMENTARY